Fadl Hamouche
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fadl Hamouche has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Abdulghani Khogeer
Rabigh, King Abdulaziz University
1 shared publication - Abdullah Alahmari
Division of Urology, Department of Surgery, McGill University, Montreal, QC H3A 0G4, Canada
1 shared publication - Abdullah Mousa Alzahrani
Department of Urology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia
1 shared publication Abdulmalik Addar
Department of Surgery, Division of Urology, McGill University, Montreal, Canada
1 shared publication- Abdulmalik Addar
Division of Urology, McGill University, Montreal, Canada
1 shared publication - Adel Arezki
Division of Urology, McGill University, Montreal, Canada
1 shared publication
Latest Publications
- 30 July 2025
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-6
Predicting poor early voiding pattern after holep using maximum flow rate (Q-max) as an objective outcome
Purpose Holmium laser enucleation of the prostate (HoLEP) is recognized as a gold standard treatment for benign prostatic hyperplasia (BPH), providing durable improvements in quality of life and symptomatology. However, a subset of patients continues to experience suboptimal voiding outcomes postoperatively. This study aims to identify preoperative predictors of poor voiding patterns, as objectively measured by maximum urinary flow rate (Q-max), following HoLEP. Methods We retrospectively analyzed 1121 patients who underwent HoLEP at McGill University Health Centre from January 2006 to December 2022. Inclusion required a minimum one-month follow-up with documented Q-max. Data collected included demographics, preoperative parameters (IPSS, PSA, prostate volume), operative details, and postoperative outcomes. Poor voiding was defined as a Q-max < 15 ml/sec at one month postoperatively. Bilateral stepwise regression identified candidate predictors, which were further evaluated using logistic regression. Results The cohort had a mean age of 70.7 years (SD 8.3), mean prostate volume of 98.3 mL, and mean PSA of 6.7 ng/dL (SD 9.1). Preoperative medical therapy included alpha blockers (63.6%) and combination therapy (33%). Multivariate analysis revealed that advanced age (OR = 1.01 per year; 95% CI, 1.00–1.01; p = 0.017), diabetes mellitus (OR = 1.29; 95% CI, 1.03–1.62; p = 0.028), and preoperative combination BPH therapy (OR = 1.17; 95% CI, 1.02–1.34; p = 0.023) were independently associated with poor postoperative Q-max, whereas increased enucleated tissue weight was protective (OR = 0.998; 95% CI, 0.996–0.999; p = 0.005). Conclusions Advanced age, diabetes mellitus, and combination BPH therapy independently predict suboptimal voiding after HoLEP, highlighting the need for tailored preoperative evaluation and management strategies.
- 30 July 2025
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-6
Predicting poor early voiding pattern after holep using maximum flow rate (Q-max) as an objective outcome
Purpose Holmium laser enucleation of the prostate (HoLEP) is recognized as a gold standard treatment for benign prostatic hyperplasia (BPH), providing durable improvements in quality of life and symptomatology. However, a subset of patients continues to experience suboptimal voiding outcomes postoperatively. This study aims to identify preoperative predictors of poor voiding patterns, as objectively measured by maximum urinary flow rate (Q-max), following HoLEP. Methods We retrospectively analyzed 1121 patients who underwent HoLEP at McGill University Health Centre from January 2006 to December 2022. Inclusion required a minimum one-month follow-up with documented Q-max. Data collected included demographics, preoperative parameters (IPSS, PSA, prostate volume), operative details, and postoperative outcomes. Poor voiding was defined as a Q-max < 15 ml/sec at one month postoperatively. Bilateral stepwise regression identified candidate predictors, which were further evaluated using logistic regression. Results The cohort had a mean age of 70.7 years (SD 8.3), mean prostate volume of 98.3 mL, and mean PSA of 6.7 ng/dL (SD 9.1). Preoperative medical therapy included alpha blockers (63.6%) and combination therapy (33%). Multivariate analysis revealed that advanced age (OR = 1.01 per year; 95% CI, 1.00–1.01; p = 0.017), diabetes mellitus (OR = 1.29; 95% CI, 1.03–1.62; p = 0.028), and preoperative combination BPH therapy (OR = 1.17; 95% CI, 1.02–1.34; p = 0.023) were independently associated with poor postoperative Q-max, whereas increased enucleated tissue weight was protective (OR = 0.998; 95% CI, 0.996–0.999; p = 0.005). Conclusions Advanced age, diabetes mellitus, and combination BPH therapy independently predict suboptimal voiding after HoLEP, highlighting the need for tailored preoperative evaluation and management strategies.
- 10 April 2025
- Published by Elsevier in European Urology Focus
- Vol. 11 (5) , 841
Reply to Chi-Wen Lo, Shen Shiou Tseng, and Yao-Chou Tsai’s Letter to the Editor re: Tarek Benzouak, Abdulmalik Addar, Michael A. Prudencio-Brunello, et al. Comparative Analysis of Holmium Laser Enucleation of the Prostate (HoLEP) and Robotic-Assisted Simple Prostatectomy (RASP) in BPH Management: A Systematic Review and Meta-Analysis. J Urol. In press. https://doi.org/10.1097/JU.0000000000004297
- 10 April 2025
- Published by Elsevier in European Urology Focus
- Vol. 11 (5) , 841
Reply to Chi-Wen Lo, Shen Shiou Tseng, and Yao-Chou Tsai’s Letter to the Editor re: Tarek Benzouak, Abdulmalik Addar, Michael A. Prudencio-Brunello, et al. Comparative Analysis of Holmium Laser Enucleation of the Prostate (HoLEP) and Robotic-Assisted Simple Prostatectomy (RASP) in BPH Management: A Systematic Review and Meta-Analysis. J Urol. In press. https://doi.org/10.1097/JU.0000000000004297
- 1 January 2023
- Published by Springer Nature
- p. 439-463
Ureteral Stones